New T-cell engagers and ADCs show survival gains in pretreated small cell lung cancer, signaling long-awaited progress and more treatment options for patients. New therapies like T-cell engagers and ...

Lung cancer remains the leading cause of cancer-related mortality worldwide. Although small cell lung cancer (SCLC) accounts for a smaller percentage of lung cancer cases, it has remained a ...

The five-year survival rate for all cancers combined has reached a historic 70%, according to the latest American Cancer Society Cancer Statistics 2026 report, based on all people diagnosed between ...

Vaxira uses molecular mimicry to help the immune system attack advanced lung cancer cells, extending survival and avoiding many side effects of conventional therapies.